HOME >> MEDICINE >> NEWS
After bypass surgery, women have worse quality of life than men

DURHAM, N.C. A study by Duke University Medical Center researchers has found that women do not derive the same long-term quality-of-life benefits as men following coronary artery bypass surgery. This conclusion was evident even after the researchers statistically adjusted their data to allow for the greater number of preoperative risk factors in women than in men.

The researchers speculate that there may be two reasons for this clear gender discrepancy either women may not experience the same level of physical benefits from the surgery as men, or their lowered quality of life is less related to cardiac health than men.

The results of the Duke study were published today (Nov. 24, 2003) in the journal Psychosomatic Medicine. The research was support by the National Institutes of Health and the American Heart Association (AHA).

"We know that in general women receiving bypass surgery are sicker, older, more likely to live alone and have other preoperative differences that would appear to explain a compromised quality of life," said lead author Barbara Phillips-Bute, Ph.D., assistant research professor in department of anesthesiology. "However, when we control for all these factors, a significant difference still exists."

Both the American College of Cardiology and the AHA have issued guidelines stating that when physicians and patients discuss the option of surgery, quality of life should be considered as an important factor along with survival, Phillips-Bute said. When all bypass patients are taken together, the surgery does improve quality of life, she continued, adding however that little is known about the gender differences.

To better understand these gender differences, the Duke team enrolled in a clinical trial 280 patients (96 women and 184 men) who were to receive bypass surgery.

All were given a battery of tests that measured quality of life and cognitive status prior to surgery and one year later. The quality-
'"/>

Contact: Richard Merritt
merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
24-Nov-2003


Page: 1 2 3

Related medicine news :

1. Aftermath of September 11th on creativity: Psychoanalysts host major literary figures
2. Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke
3. New Method Assesses Risk Of Advanced Cancer After Prostate Removal
4. Carnegie Mellon, Pitt Team Show That Adult Brains Compensate For Damage To Language Systems After Stroke Occurs
5. NICHD-Funded Researchers Show Estrogen Effects On Brain After Menopause
6. Poor Health In Pregnancy And After Childbirth Tied To History Of Abuse
7. Member Of The "Coasters" Making A Real-Life Comeback After Experiencing An Aneurysm Two Years Ago
8. Study Finds Clot-Busting Drug Ineffective Or Even Harmful If Not Used Soon After A Stroke
9. Small Risk Of Pill Disappears After Ten Years
10. Thymus May Hold Clue To Rebuilding Immune System After HIV
11. Study Offers Hope For Immune Reconstitution After HIV Infection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: After bypass surgery women have worse quality life than men

(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: